Protocol for studying the efficiency of ChemoCalc software in helping patients to understand drug treatment costs for breast cancer: A multicenter, open-label, randomized phase 2 study.
Kuba S, Moriuchi H, Yamanouchi K, Shibata K, Yano H, Oikawa M, Maeda S, Meng X, Morita M, Hatachi T, Otsubo R, Matsumoto M, Miyamoto J, Kanetaka K, Taniguchi H, Nagayasu T, Eguchi S.
Kuba S, et al. Among authors: eguchi s.
Contemp Clin Trials Commun. 2021 Feb 11;21:100739. doi: 10.1016/j.conctc.2021.100739. eCollection 2021 Mar.
Contemp Clin Trials Commun. 2021.
PMID: 33718655
Free PMC article.